Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss

NCT07506512 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT07506512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07506512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss
Lead sponsor
University of Pennsylvania
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2027
Completion date
December 31, 2031
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early pregnancy loss